Market Failure and the Poverty of New Drugs in Maternal Health

Published By: Plos Medicine on eSS | Published Date: January, 30 , 2008

A new survey finds that only 17 drugs are under active development for maternal health indications, which is less than 3% of the pipeline in cardiovascular health (660 drugs). The international agencies have forgotten pregnant women. Given the unacceptably high number of maternal and perinatal deaths each year, it is high time to address this issue. [Policy Forum January 2008, Volume 5, Issue 1].

Author(s): Nicholas M Fisk, Rifat Atun | Posted on: Jan 30, 2008 | Views(2290) | Download (1199)


Member comments

Submit

No Comments yet! Be first one to initiate it!

Creative Commons License